NMPA approves Rigen-Bio’s disposable thyroid biopsy needle for marketing in China

Release time :2022-06-13

Recently, Shanghai Municipal Drug Administration approves Rigen-Bio’s disposable thyroid biopsy needle, which was independently developed and designed for marketing in China. [Registration Certificate No. 20212140622] And filed with the State Drug Administration (NMPA). 

The needle specifically designed for thyroid biopsy is the only product in China to obtain thyroid tissue samples through percutaneous puncture with many advantages , such as easy to operate, and sampling accurately. There are 7 different specifications, 26G, 25G, 24G, 23G, 22G, 21G, 20G for clinical choices.

细针 内容图2 新600.png